Pediatrics in Review
HOME HELP CONTACT US SUBSCRIPTIONS CME ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Rapid Responses: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Rapid Responses are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Phelps, D. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Phelps, D. L.

Retinopathy of Prematurity

Dale L. Phelps MD1
 1 Director, Program in Neonatology; Professor of Pediatrics and of Ophthalmology, University of Rochester School of Medicine and Dentistry, Rochester, NY.

Retinopathy of prematurity is a common disorder among extremely low-birthweight preterm infants and may cause total vision loss in as many as 2% to 4% of those weighing less than 2 pounds at birth. Regular examinations begun in the neonatal intensive care unit permit early detection and treatment of progressive ROP and allow a reduction in visual impairment.

Infants whose ROP has regressed should continue to receive regular ophthalmologic follow-up for the detection and treatment of myopia and strabismus and, if they have cicatricial sequelae, late retinal detachments as teens or adults. Early intervention and special education programs are important for the children whose vision loss is significant.




This article has been cited by other articles:


Home page
 IOVSHome page
J. M. Barnett, G. W. McCollum, J. A. Fowler, J. J.-W. Duan, J. D. Kay, R.-Q. Liu, D. P. Bingaman, and J. S. Penn
Pharmacologic and Genetic Manipulation of MMP-2 and -9 Affects Retinal Neovascularization in Rodent Models of OIR
Invest. Ophthalmol. Vis. Sci., February 1, 2007; 48(2): 907 - 915.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
S. Sarlos, B. Rizkalla, C. J. Moravski, Z. Cao, M. E. Cooper, and J. L. Wilkinson-Berka
Retinal Angiogenesis Is Mediated by an Interaction between the Angiotensin Type 2 Receptor, VEGF, and Angiopoietin
Am. J. Pathol., September 1, 2003; 163(3): 879 - 887.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
D. K. Richardson
A Woman With an Extremely Premature Newborn
JAMA, September 26, 2001; 286(12): 1498 - 1505.
[Full Text] [PDF]

Home page
 JEMHome page
I. Nunes, R. D. Higgins, L. Zanetta, P. Shamamian, and S. P. Goff
c-Abl Is Required for the Development of Hyperoxia-induced Retinopathy
J. Exp. Med., June 18, 2001; 193(12): 1383 - 1392.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
J. S. Penn, V. S. Rajaratnam, R. J. Collier, and A. F. Clark
The Effect of an Angiostatic Steroid on Neovascularization in a Rat Model of Retinopathy of Prematurity
Invest. Ophthalmol. Vis. Sci., January 1, 2001; 42(1): 283 - 290.
[Abstract] [Full Text]

Home page
 Evid. Based Nurs.Home page
J. M McGrath
Supplemental oxygen did not reduce progression of pre-threshold retinopathy of prematurity in infants
Evid. Based Nurs., October 1, 2000; 3(4): 114 - 114.
[Full Text]


HOME HELP CONTACT US SUBSCRIPTIONS CME ARCHIVE SEARCH TABLE OF CONTENTS
Pediatrics Pediatrics in Review
Copyright © 1995 by the American Academy of Pediatrics.